These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16573714)

  • 1. Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibition.
    Blanchet B; Hulin A; Ghaleh B; Giraudier S; Jouault H; Astier A
    Fundam Clin Pharmacol; 2006 Apr; 20(2):137-44. PubMed ID: 16573714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation].
    Blanchet B
    Ann Pharm Fr; 2008 Mar; 66(2):96-101. PubMed ID: 18570908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood.
    Sellar KJ; van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J
    Anal Biochem; 2006 Nov; 358(1):104-10. PubMed ID: 16979577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.
    Tanaka S; Nakajima K; Hirano T; Oka K; Saito T; Wakata N
    J Pharm Pharmacol; 2008 Oct; 60(10):1341-6. PubMed ID: 18812027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B; Duvoux C; Costentin CE; Barrault C; Ghaleh B; Salvat A; Jouault H; Astier A; Tod M; Hulin A
    Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12.
    van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J
    Biochem Pharmacol; 2009 Apr; 77(7):1206-12. PubMed ID: 19154728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
    J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephrosis.
    Hirano T; Fukushima H; Sasaki Y; Yoshikawa N; Yoshida M; Oka K
    Int Immunopharmacol; 2006 Jun; 6(6):924-34. PubMed ID: 16644478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
    Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
    Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M; Zegarska J; Pawłowska M; Wyzgał J; Ciszek M; Paczek L
    Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the Calcineurin Pathway in Patients on the Liver Transplantation Waiting List: Factors of Variability and Response to Tacrolimus Inhibition.
    Noceti O; Pouché L; Esperón P; Lens D; Vital M; Touriño C; Gerona S; Woillard JB; Marquet P
    Clin Chem; 2017 Nov; 63(11):1734-1744. PubMed ID: 29054923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity.
    Fukudo M; Yano I; Masuda S; Okuda M; Inui K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):816-25. PubMed ID: 15383634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
    Brandhorst G; Tenderich G; Zittermann A; Oezpeker C; Koerfer R; Oellerich M; Armstrong VW
    Ther Drug Monit; 2008 Feb; 30(1):113-6. PubMed ID: 18223473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of serine/threonine protein phosphatase type 2B PP2B in lymphocytes by HPLC.
    Blanchet B; Hulin A; Duvoux C; Astier A
    Anal Biochem; 2003 Jan; 312(1):1-6. PubMed ID: 12479828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.
    Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
    Ren Fail; 2007; 29(6):679-84. PubMed ID: 17763162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressant calcineurin inhibitors phase shift circadian rhythms and inhibit circadian responses to light.
    Katz ME; Simonetta SH; Ralph MR; Golombek DA
    Pharmacol Biochem Behav; 2008 Oct; 90(4):763-8. PubMed ID: 18590756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Superoxide dismutase activity in selected morphotic components of human peripheral blood].
    Grabowska B; Lipecka K; Daniszewska K
    Med Pr; 1987; 38(4):239-43. PubMed ID: 3695929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin activity assay measurement by liquid chromatography-tandem mass spectrometry in the multiple reaction monitoring mode.
    Carr L; Gagez AL; Essig M; Sauvage FL; Marquet P; Gastinel LN
    Clin Chem; 2014 Feb; 60(2):353-60. PubMed ID: 24281780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.